Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk
Authors:
- Morten S. OlesenMOMorten S. Olesen
- Geisinger MyCode Community Health InitiativeGIGeisinger MyCode Community Health Initiative
Open Access
- 1 August 2024
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 9 (8) , 732-740
Abstract
Importance: Atrial fibrillation (AF) has a substantial genetic component. The importance of polygenic risk is well established, while the contribution of rare variants to disease risk warrants characterization in large cohorts.Objective: To identify rare predicted loss-of-function (pLOF) variants associated with AF and elucidate their role in risk of AF, cardiomyopathy (CM), and heart failure (HF) in combination with a polygenic risk score (PRS).Design, Setting, and Participants: This was a genetic association and nested case-control study. The impact of rare pLOF variants was evaluated on the risk of incident AF. HF and CM were assessed in cause-specific Cox regressions. End of follow-up was July 1, 2022. Data were analyzed from January to October 2023. The UK Biobank enrolled 502 480 individuals aged 40 to 69 years at inclusion in the United Kingdom between March 13, 2006, and October 1, 2010. UK residents of European ancestry were included. Individuals with prior diagnosis of AF were excluded from analyses of incident AF.Exposures: Rare pLOF variants and an AF PRS.Main Outcomes and Measures: Risk of AF and incident HF or CM prior to and subsequent to AF diagnosis.Results: A total of 403 990 individuals (218 489 [54.1%] female) with a median (IQR) age of 58 (51-63) years were included; 24 447 were diagnosed with incident AF over a median (IQR) follow-up period of 13.3 (12.4-14.0) years. Rare pLOF variants in 6 genes (TTN, RPL3L, PKP2, CTNNA3, KDM5B, and C10orf71) were associated with AF. Of these, TTN, RPL3L, PKP2, CTNNA3, and KDM5B replicated in an external cohort. Combined with high PRS, rare pLOF variants conferred an odds ratio of 7.08 (95% CI, 6.03-8.28) for AF. Carriers with high PRS also had a substantial 10-year risk of AF (16% in female individuals and 24% in male individuals older than 60 years). Rare pLOF variants were associated with increased risk of CM both prior to AF (hazard ratio [HR], 3.13; 95% CI, 2.24-4.36) and subsequent to AF (HR, 2.98; 95% CI, 1.89-4.69).Conclusions and Relevance: Rare and common genetic variation were associated with an increased risk of AF. The findings provide insights into the genetic underpinnings of AF and may aid in future genetic risk stratification.Keywords
This publication has 28 references indexed in Scilit:
- Loss of KDM5B ameliorates pathological cardiac fibrosis and dysfunction by epigenetically enhancing ATF3 expressionExperimental & Molecular Medicine, 2022
- Genetic Testing for Early-Onset Atrial Fibrillation—Is It Time to Personalize Care?JAMA Cardiology, 2022
- Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia GenesJAMA Cardiology, 2022
- Exome sequencing and analysis of 454,787 UK Biobank participantsNature, 2021
- Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia GenesJAMA Cardiology, 2021
- Rare truncating variants in the sarcomeric protein titin associate with familial and early-onset atrial fibrillationNature Communications, 2018
- Biobank-driven genomic discovery yields new insight into atrial fibrillation biologyNature Genetics, 2018
- Multi-ethnic genome-wide association study for atrial fibrillationNature Genetics, 2018
- Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillationNature Genetics, 2017
- A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillationNature Communications, 2016